Latest news
Systemic Delivery of Biologics via Inhalation: Overcoming Injection Aversion in Modern Therapies
That was the title of the talk by Dr Orest Lastow, CTO at Iconovo, at the meeting New updates in Drug Formulation & Bioavailability organized by Life Science…
Grundaren av Iconovo, Dr Orest Lastow, om att vara sci-fi-författare
Grundaren av Iconovo, Dr Orest Lastow, har blivit intervjuad av Life Science Sweden om sin nya parallella karriär som sci-fi-författare. Orest kombinerar…
Press releases
Jul 12, 2024, 08:30
News
IR
English
Regulatory
MAR
Report
Interim
Q2
May 24, 2024, 17:35
News
IR
English
Report
Annual
May 21, 2024, 11:15
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
May 15, 2024, 13:50
News
IR
English
Regulatory
MAR
Corporate Action
Other
May 15, 2024, 13:50
News
IR
Swedish
Regulatory
MAR
Corporate Action
Other
May 06, 2024, 08:30
News
IR
Swedish
Corporate Action
Other
May 06, 2024, 08:30
News
IR
English
Corporate Action
Other
Apr 25, 2024, 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Report
Annual
Apr 19, 2024, 09:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Mar 11, 2024, 09:57
News
IR
Swedish
Corporate Action
Other
Mar 11, 2024, 09:57
News
IR
English
Corporate Action
Other
Mar 06, 2024, 13:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
Mar 05, 2024, 10:45
News
IR
English
Corporate Action
Other
Mar 05, 2024, 10:45
News
IR
Swedish
Corporate Action
Other
Feb 15, 2024, 20:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Feb 15, 2024, 19:35
News
IR
English
Regulatory
MAR
Report
Interim
Yearend
Feb 15, 2024, 19:35
News
IR
Swedish
Regulatory
MAR
Report
Interim
Yearend
Feb 15, 2024, 19:30
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
mfn-cus-top-disclaimer
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
Interim CEO
Anders Månsson
Mail: anders.mansson@iconovo.se